About Index Trending news
Lists
Pricing
BioTime

BioTime

BioTime

BioTime, a biotechnology company, is engaged in biomedical R&D in regenerative medicine and stem cell therapeutics.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Grant
$2,000,000
Post-IPO equity
$10,550,000
Employees

Team size

50+
Locations
HQ
Headquarters
$2,000,000 Grant
businesswire

BioTime Announces $2 Million Grant for Further Development of OpRegen® for Dry-AMD

$2,200,000 Grant
businesswire

BioTime Announces $2.2 Million Grant for Further Development of Dry-AMD Program | Business Wire